Literature DB >> 8349688

Guanine nucleotide-specific phosphate transfer by guanine nucleotide-binding regulatory protein beta-subunits. Characterization of the phosphorylated amino acid.

T Wieland1, B Nürnberg, I Ulibarri, S Kaldenberg-Stasch, G Schultz, K H Jakobs.   

Abstract

One major substrate protein was phosphorylated with [gamma-32P]GTP in membranes of human leukemia (HL-60) cells. The phosphoprotein comigrated with beta-subunits of heterotrimeric GTP-binding proteins (G proteins) in different gel systems. Upon solubilization of the phosphorylated membranes, the phosphoprotein could be immunoprecipitated by a G protein beta-subunit-specific antiserum. The beta-subunit phosphorylation was transient and was found to be specific for GTP and its analog, guanosine 5'-O-(gamma-thio)triphosphate. When phosphorylated membranes were incubated with various nucleotides, the bound phosphate was specifically removed by GDP, suggesting that the phosphate can be retransferred onto GDP. Divalent cations, preferentially Mg2+ and Mn2+, were required for both phosphorylation and dephosphorylation. The phosphorylation was stable against treatment with NaOH but sensitive to treatment with heat, HCl, and hydroxylamine. Moreover, treatment of the membranes with the histidine-modifying agent, diethyl pyrocarbonate, resulted in a loss in phosphate incorporation. The data suggest that G protein beta-subunits are involved in a guanine nucleotide-specific enzymatic activity transferring the gamma-phosphate from GTP to GDP, presumably at G protein alpha-subunits, via a phosphohistidine intermediate.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8349688

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  Chronic morphine induces the concomitant phosphorylation and altered association of multiple signaling proteins: a novel mechanism for modulating cell signaling.

Authors:  S Chakrabarti; M Oppermann; A R Gintzler
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

Review 2.  Chasing phosphohistidine, an elusive sibling in the phosphoamino acid family.

Authors:  Jung-Min Kee; Tom W Muir
Journal:  ACS Chem Biol       Date:  2011-12-09       Impact factor: 5.100

Review 3.  Interaction of nucleoside diphosphate kinase B with heterotrimeric G protein betagamma dimers: consequences on G protein activation and stability.

Authors:  Thomas Wieland
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-01-03       Impact factor: 3.000

Review 4.  Structural determinants involved in the formation and activation of G protein betagamma dimers.

Authors:  William E McIntire
Journal:  Neurosignals       Date:  2009-02-12

Review 5.  Detection and analysis of protein histidine phosphorylation.

Authors:  Paul G Besant; Paul V Attwood
Journal:  Mol Cell Biochem       Date:  2009-04-23       Impact factor: 3.396

Review 6.  G protein βγ subunits: central mediators of G protein-coupled receptor signaling.

Authors:  A V Smrcka
Journal:  Cell Mol Life Sci       Date:  2008-07       Impact factor: 9.261

7.  Association of nucleoside diphosphate kinase with pancreatic zymogen granules: effects of local GTP generation on granule membrane characteristics.

Authors:  S J Marciniak; J M Edwardson
Journal:  Biochem J       Date:  1996-05-15       Impact factor: 3.857

Review 8.  Phosphotransfer reactions as a means of G protein activation.

Authors:  L Piacentini; F Niroomand
Journal:  Mol Cell Biochem       Date:  1996 Apr 12-26       Impact factor: 3.396

Review 9.  Protein histidine [de]phosphorylation in insulin secretion: abnormalities in models of impaired insulin secretion.

Authors:  Anjaneyulu Kowluru; Susanne Klumpp; Josef Krieglstein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-04-06       Impact factor: 3.000

10.  Plasma membrane-associated nucleoside diphosphate kinase (nm23) in the heart is regulated by beta-adrenergic signaling.

Authors:  Susanne Lutz; Roman A Mura; Hans Joerg Hippe; Christiane Tiefenbacher; Feraydoon Niroomand
Journal:  Br J Pharmacol       Date:  2003-10-14       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.